Engineered Extracellular Vesicle-Delivered CRISPR/Cas9 for Radiotherapy Sensitization of GlioblastomaXiao Liu, Jintao Gu, Bo Jia et al.|ACS Nano|2023Cited by 116
Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signalingXiao Liu, Jintao Gu, Qingdong Guo et al.|Journal of Nanobiotechnology|2023Cited by 38
Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcomaMing‐Rui Du, Jixian Qian, Jintao Gu et al.|Journal of Experimental & Clinical Cancer Research|2022Cited by 28
Biomimetic Dendritic Cell-Based Nanovaccines for Reprogramming the Immune Microenvironment to Boost Tumor ImmunotherapyWeizhong Wang, Jintao Gu, Cheng Zou et al.|ACS Nano|2024Cited by 26
Kill two birds with one stone: Engineered exosome-mediated delivery of cholesterol modified YY1-siRNA enhances chemoradiotherapy sensitivity of glioblastomaXiao Liu, Jintao Gu, Zhengcong Cao et al.|Frontiers in Pharmacology|2022Cited by 25